S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
FRA:BAYN

Bayer Aktiengesellschaft Stock Forecast, Price & News

€48.32
+0.13 (+0.27 %)
(As of 10/22/2021 12:00 AM ET)
Add
Compare
Today's Range
€48.05
€48.53
50-Day Range
€45.21
€48.62
52-Week Range
€91.58
€123.82
Volume1.49 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.


Bayer Aktiengesellschaft logo

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc. and Forschungszentrum Jülich GmbH; strategic research partnership with University of Oxford to develop novel gynecological therapies; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Headlines

Bayer Aktiengesellschaft (BAYN.F)
October 22, 2021 |  uk.finance.yahoo.com
Keeping Carbon in Check
October 20, 2021 |  finance.yahoo.com
Bayer shares up after first trial win over Roundup
October 6, 2021 |  finance.yahoo.com
Changing the Equation
October 6, 2021 |  finance.yahoo.com
BWXT Medical, Bayer AG Ink Agreement On Actinium-225
September 16, 2021 |  finance.yahoo.com
Bayer's (BAYRY) Chronic Cough Candidate Meets Efficacy Goal
September 7, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
103,824
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.66 out of 5 stars

Analyst Opinion: 3.3Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Bayer Aktiengesellschaft (FRA:BAYN) Frequently Asked Questions

Is Bayer Aktiengesellschaft a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bayer Aktiengesellschaft in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Bayer Aktiengesellschaft stock.
View analyst ratings for Bayer Aktiengesellschaft
or view top-rated stocks.

What stocks does MarketBeat like better than Bayer Aktiengesellschaft?

Wall Street analysts have given Bayer Aktiengesellschaft a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bayer Aktiengesellschaft wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Bayer Aktiengesellschaft's stock been impacted by Coronavirus (COVID-19)?

Bayer Aktiengesellschaft's stock was trading at €56.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BAYN shares have decreased by 13.8% and is now trading at €48.32.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for BAYN?

11 analysts have issued 1 year price targets for Bayer Aktiengesellschaft's stock. Their forecasts range from €43.00 to €85.00. On average, they anticipate Bayer Aktiengesellschaft's stock price to reach €62.80 in the next twelve months. This suggests a possible upside of 30.0% from the stock's current price.
View analysts' price targets for Bayer Aktiengesellschaft
or view top-rated stocks among Wall Street analysts.

Who are Bayer Aktiengesellschaft's key executives?

Bayer Aktiengesellschaft's management team includes the following people:
  • Mr. Werner Baumann, Chairman of Management Board, CEO & Chief Sustainability Officer (Age 59, Pay $5.29M)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 52, Pay $1.94M)
  • Mr. Liam Condon, Member of Management Board & Pres Crop Science Division (Age 53, Pay $2.67M)
  • Mr. Heiko W. J. Schipper, Member of Management Board & Pres of the Consumer Health Division (Age 52, Pay $2.44M)
  • Mr. Stefan Oelrich, Head of the Pharmaceuticals Division & Member of the Board of Management (Age 53, Pay $2.83M)
  • Ms. Sarena S. Lin, Chief Transformation & Talent Officer, Labor Director and Member of Management Board (Age 50)
  • Mr. Bernd-Peter Bier, Head of Accounting and Head of Taxes (Age 54)
  • Mr. Oliver Maier, Head of Investor Relations
  • Dr. Gabriel Harnier, Head of Law, Patents & Compliance (Age 50)
  • Mr. Michael Preuss, Head of Communications, Gov. Relations and Corp. Brand

What other stocks do shareholders of Bayer Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer Aktiengesellschaft investors own include Hawkins (HWKN), CA (CA), Bayer Aktiengesellschaft (BAYRY), Basf (BAS), BlackRock (BLK), General Electric (GE), The Coca-Cola (KO), Allianz (ALV), Alibaba Group (BABA) and Daimler (DAI).

What is Bayer Aktiengesellschaft's stock symbol?

Bayer Aktiengesellschaft trades on the FRA under the ticker symbol "BAYN."

What is Bayer Aktiengesellschaft's stock price today?

One share of BAYN stock can currently be purchased for approximately €48.32.

How many employees does Bayer Aktiengesellschaft have?

Bayer Aktiengesellschaft employs 103,824 workers across the globe.

What is Bayer Aktiengesellschaft's official website?

The official website for Bayer Aktiengesellschaft is www.bayer.de.

Where are Bayer Aktiengesellschaft's headquarters?

Bayer Aktiengesellschaft is headquartered at Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany.

How can I contact Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.


This page was last updated on 10/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.